{"name":"ClearPoint Neuro, Inc.","slug":"clearpoint","ticker":"CLPT","exchange":"NASDAQ","domain":"clearpointneuro.com","description":"ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame, computer workstation, and in-room monitor; and ClearPoint disposables, which consist of SmartFrame trajectory device, a hand controller and related accessories, and its SmartFlow Neuro cannula. It also provides ClearPoint software, which guides the physician in surgical planning, device alignment, navigation to the target, and procedure monitoring; ClearPoint Prism Neuro laser therapy system to necrotize or coagulate soft tissue; and IRRAflow system, an active fluid exchange platform. In addition, the company offers consulting services to its pharmaceutical and other medical technology partners, such as benchtop testing, preclinical studies, clinical trial support, regu","hq":"Solana Beach, CA","founded":0,"employees":"172","ceo":"Joseph Burnett","sector":"Neurosurgery Navigation / MedTech","stockPrice":13.18,"stockChange":0.99,"stockChangePercent":8.12,"marketCap":"$395M","metrics":{"revenue":36971000,"revenueGrowth":34,"grossMargin":61.4,"rdSpend":13897000,"netIncome":-25540000,"cash":45923000,"dividendYield":0,"peRatio":-15.1,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-27","type":"earnings","headline":"ClearPoint Neuro Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"ClearPoint Neuro reported its financial results for the fourth quarter and full year 2023, with revenue of $23.4 million and a net loss of $14.3 million.","drugName":"","sentiment":"neutral"},{"date":"2023-11-07","type":"deal","headline":"ClearPoint Neuro Announces Collaboration with Brainlab to Enhance Neurosurgery Navigation Capabilities","summary":"ClearPoint Neuro has entered into a collaboration with Brainlab to integrate their navigation systems and enhance neurosurgery navigation capabilities.","drugName":"","sentiment":"positive"},{"date":"2023-08-14","type":"regulatory","headline":"ClearPoint Neuro Receives FDA Clearance for Expanded Indications for ClearPoint Neuro Navigation System","summary":"ClearPoint Neuro has received FDA clearance for expanded indications for its ClearPoint Neuro Navigation System, enabling the use of the system in additional neurosurgical procedures.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTE9uTXE5dTVuRXQzWS1Sc3VvWjFXWlFwdkNYbDBwaEJGYVVqTzdua1pBcng1Z3BiQXRJNlQ1Um1QVmVmcVFTMllnWkZtcC1CY0h1c0E?oc=5","date":"2026-04-06","type":"pipeline","source":"Yahoo Finance UK","summary":"ClearPoint Neuro, Inc. (CLPT) stock price, news, quote and history - Yahoo Finance UK","headline":"ClearPoint Neuro, Inc. (CLPT) stock price, news, quote and history","sentiment":"neutral"},{"date":"2026-03-17","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-03-17","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNYlNIN0ZicDZZbTVEb2VXMl80YUQzVURuS0EyV3FCcndGTTJuY2J5ZHpiNEtpY0lPcExnRFd4N1N2MVJGMGlWalhqcXdaaTNlQThHNDl2TEJHM0Y2ZmcwVzlOSDJ5cGthZTBTQ0wyZHNVaHB1U3dYeW0zYlhiSFNxVnZLMnZVZ1dyejhqQlUtRGVjYWNpZTA4MkZtQjJFSDlWbzRadDJZQnk?oc=5","date":"2025-11-03","type":"pipeline","source":"TechStock²","summary":"ClearPoint Neuro (CLPT) Stock Skyrockets on Brain Therapy Breakthroughs – 2025 Deep Dive - TechStock²","headline":"ClearPoint Neuro (CLPT) Stock Skyrockets on Brain Therapy Breakthroughs – 2025 Deep Dive - TechStock²","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPdjlZRVFWOTYzVU5wYzlnM1RaQTVmdndGZTZ4WXpDQ1d1VnY5NWcxdl8zRWNGMEpCVzdDY2oyNW1LRGVYRGowOWNHRmpVOVBjTDBKVlg4VzFfT1VjY3pqUjhIbnhNd205TE8tWUpQZ2dTRDNNTi1wNVB0a2pIeHBSTkc4RGY2bkZmSVVfNjRsSDRlZWhX?oc=5","date":"2025-10-02","type":"pipeline","source":"Seeking Alpha","summary":"ClearPoint Neuro: AMT-130 Highlights A Bright Future (NASDAQ:CLPT) - Seeking Alpha","headline":"ClearPoint Neuro: AMT-130 Highlights A Bright Future (NASDAQ:CLPT)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxOT0E2QXhOYzJIMU51ZkdqRndvWEpaZGdxU0NwT01uZjBrSjA4c3U4TkJHXzVvdDlPTWJYdGJzY0pXYmxFU2l0VThnaTdrY2JHZDhPblFWSWlxMEUzbzRKTVBpRjgyNENVOEQtbHdWQzhFQWtPbm12aHp6NXJCMzMxYjNsdG1jR25OcDQ4SHFrVFUwbVZkT1RGMlU3bw?oc=5","date":"2025-09-25","type":"pipeline","source":"Seeking Alpha","summary":"ClearPoint Neuro: Selling The Tools For Brain Therapies (NASDAQ:CLPT) - Seeking Alpha","headline":"ClearPoint Neuro: Selling The Tools For Brain Therapies (NASDAQ:CLPT)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9rU1lLR3RrcjdyTHFEbzdrMjBZQ1pRckpPQTU0Y1NyMUhEWTc3V0llYlRvb2pLS3ZhOE9KOXgzcUtqNWZrZVE2TGR3VE1aXzdJUTBr?oc=5","date":"2025-04-25","type":"pipeline","source":"Stock Titan","summary":"CLPT Stock Price, News & Analysis - Stock Titan","headline":"CLPT Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNMk1IWjNLSzBtXy1MZml5X2NlUkVWeFROaDBIX2JMRHJidGdPVXNiZk91Tlo3MGo1LTc1TXZQdHc0eTlLN0FORFNRM1U5b2U4V0lVUHBDaW9zcWYwcV9lcnZSZmlYWjc4cW1Fc0RsUHdsVzRTUjRoVmRDcGEtZ0phd29KSzFqTGQ5bjg3elQwMHpLMTdjb2QtblBFYlhNck1RYnVRNW81Yw?oc=5","date":"2024-11-13","type":"regulatory","source":"newswire.com","summary":"ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain - newswire.com","headline":"ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOU0FoOEkzcTVLbEJGSzRJQ1RmQ0VLbXM5S0pNdE1ZUEkyTWRjVXdQWndWeV9ZWlBEUzNIZkRXSGdtU29CS2VpUUxvTHZ4TEdtMnNMalBhRi1kdW1XeENybHh0Q1FOTk1ZWlVOU0RmV3dJTkw5TUpIMzlyOVdMNjVzcmZLczhxNTdxUVFpMnFoSDdyanRVOGZuWnA4SjNXRzNsdmc?oc=5","date":"2024-08-08","type":"pipeline","source":"Seeking Alpha","summary":"ClearPoint Neuro: My Favorite Growth Stock (NASDAQ:CLPT) - Seeking Alpha","headline":"ClearPoint Neuro: My Favorite Growth Stock (NASDAQ:CLPT)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPQlZhTUdjbERySUxZYkpLYTd4XzNXWnVsNk92RHg1b3BrdEh0YXBLdFFoY0VQQk5HYmtGbXkwcjVpbUlBTjlhVlE3OV8tNHhuQ2tKak5CUkdwWHJOLWlpckxIajRQYWE3RlozSVhvWmY5akhjRVF5THlZTGNvV0VkclF2TW0wTlZGMWt6YTM1dFZOeG02TXdkLVdzalNPSXdLM2pYYXNFSWs?oc=5","date":"2022-09-20","type":"pipeline","source":"BioSpace","summary":"ClearPoint Neuro Announces Appointment of Mazin Sabra as Chief Operating Officer - BioSpace","headline":"ClearPoint Neuro Announces Appointment of Mazin Sabra as Chief Operating Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUEFVX3lxTE1TQ05VLS1kQk5XckFuUHR3S0tZOXJiQi1lQmRpMVJPd0lfX1g4d2JVb25WQ1ZUU2hKRVJ1bkdXeHN4cTVvdFJXalRobTJPNkhO?oc=5","date":"2021-09-16","type":"pipeline","source":"The Motley Fool","summary":"ClearPoint Neuro - CLPT - Stock Price & News - The Motley Fool","headline":"ClearPoint Neuro - CLPT - Stock Price & News","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Medtronic","Brainlab","Stryker"],"therapeuticFocus":["Neurosurgery","Neurology"],"financials":{"source":"sec_edgar+yahoo","revenue":36971000,"revenuePeriod":"2025-12-31","revenueHistory":[{"value":36971000,"period":"2025-12-31"},{"value":31390000,"period":"2024-12-31"},{"value":23955000,"period":"2023-12-31"},{"value":20551000,"period":"2022-12-31"},{"value":16299000,"period":"2021-12-31"},{"value":12829000,"period":"2020-12-31"}],"grossProfit":22692000,"grossProfitHistory":[{"period":"2025-12-31","value":22692000},{"period":"2024-12-31","value":19122000},{"period":"2023-12-31","value":13614000},{"period":"2022-12-31","value":13531000}],"rdSpend":13897000,"rdSpendHistory":[{"period":"2025-12-31","value":13897000},{"period":"2024-12-31","value":12392000},{"period":"2023-12-31","value":11709000},{"period":"2022-12-31","value":10894000}],"sgaSpend":32959000,"operatingIncome":-24164000,"operatingIncomeHistory":[{"period":"2025-12-31","value":-24164000},{"period":"2024-12-31","value":-19734000},{"period":"2023-12-31","value":-22446000},{"period":"2022-12-31","value":-16332000}],"netIncome":-25540000,"netIncomeHistory":[{"period":"2025-12-31","value":-25540000},{"period":"2024-12-31","value":-18914000},{"period":"2023-12-31","value":-22089000},{"period":"2022-12-31","value":-16435000}],"eps":-0.7,"epsHistory":[{"period":"2024-12-31","value":-0.7},{"period":"2023-12-31","value":-0.9},{"period":"2022-12-31","value":-0.68},{"period":"2021-12-31","value":-0.69}],"cash":45923000,"cashHistory":[{"period":"2025-12-31","value":45923000},{"period":"2024-12-31","value":20104000},{"period":"2023-12-31","value":23140000},{"period":"2022-12-31","value":27615000}],"totalAssets":97747000,"totalLiabilities":69727000,"totalDebt":58232000,"equity":28020000,"operatingCashflow":-23925000,"operatingCashflowHistory":[{"period":"2025-12-31","value":-23925000},{"period":"2024-12-31","value":-8950000},{"period":"2023-12-31","value":-13720000},{"period":"2022-12-31","value":-16167000}],"capex":-522000,"capexHistory":[{"period":"2025-12-31","value":-522000},{"period":"2024-12-31","value":-275000},{"period":"2023-12-31","value":-1051000},{"period":"2022-12-31","value":-1146000}],"freeCashflow":-24447000,"dividendsPaid":null,"buybacks":null,"employees":172,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":10212000,"ebit":-5866000,"ebitda":-5015000,"period":"2025-12-31","revenue":10410000,"epsBasic":null,"netIncome":-7786000,"rdExpense":3237000,"epsDiluted":null,"grossProfit":6404000,"operatingIncome":-7045000},{"sga":7424000,"ebit":-5340000,"ebitda":-4914000,"period":"2025-09-30","revenue":8861000,"epsBasic":-0.21,"netIncome":-5891000,"rdExpense":3452000,"epsDiluted":-0.21,"grossProfit":5600000,"operatingIncome":-5276000},{"sga":7407000,"ebit":-5732000,"ebitda":-5106000,"period":"2025-06-30","revenue":9215000,"epsBasic":-0.21,"netIncome":-5837000,"rdExpense":3829000,"epsDiluted":-0.21,"grossProfit":5556000,"operatingIncome":-5680000},{"sga":7916000,"ebit":-6163000,"ebitda":-5829000,"period":"2025-03-31","revenue":8485000,"epsBasic":-0.22,"netIncome":-6026000,"rdExpense":3379000,"epsDiluted":-0.22,"grossProfit":5132000,"operatingIncome":-6163000},{"sga":7034000,"ebit":-5604000,"ebitda":-5133000,"period":"2024-12-31","revenue":7771000,"epsBasic":null,"netIncome":-5386000,"rdExpense":3332000,"epsDiluted":null,"grossProfit":4762000,"operatingIncome":-5604000},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-09-30","revenue":null,"epsBasic":-0.18,"netIncome":null,"rdExpense":null,"epsDiluted":-0.18,"grossProfit":null,"operatingIncome":null}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":13.18,"previousClose":12.19,"fiftyTwoWeekHigh":30.1,"fiftyTwoWeekLow":8.27,"fiftyTwoWeekRange":"8.27 - 30.1","fiftyDayAverage":10.45,"twoHundredDayAverage":14.08,"beta":1.29,"enterpriseValue":373911648,"forwardPE":-15.1,"priceToBook":13.82,"priceToSales":10.69,"enterpriseToRevenue":10.11,"enterpriseToEbitda":-17.41,"pegRatio":0,"ebitda":-21481000,"ebitdaMargin":-58.1,"freeCashflow":-9635000,"operatingCashflow":-23925000,"totalDebt":58232000,"debtToEquity":207.8,"currentRatio":5.91,"returnOnAssets":-20.4,"returnOnEquity":-95.6,"analystRating":"1.0 - Strong Buy","recommendationKey":"strong_buy","numberOfAnalysts":3,"targetMeanPrice":22,"targetHighPrice":30,"targetLowPrice":16,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":0,"insiderHeldPercent":8.2,"institutionHeldPercent":51.4,"sharesOutstanding":29986016,"floatShares":25332949,"sharesShort":4940673,"shortRatio":10,"shortPercentOfFloat":16.5,"epsTrailing":-0.9,"epsForward":-0.87,"revenuePerShare":1.31,"bookValue":0.95,"officers":[{"age":48,"name":"Mr. Joseph Michael Burnett","title":"President, CEO & Director"},{"age":40,"name":"Mr. Danilo  D'Alessandro","title":"Chief Financial Officer"},{"age":41,"name":"Mr. Jeremy L. Stigall","title":"Chief Business Officer"},{"age":45,"name":"Mr. Mazin  Sabra","title":"Chief Operating Officer"},{"age":null,"name":"Ms. Ellisa  Cholapranee J.D.","title":"General Counsel & Secretary"},{"age":60,"name":"Mr. Robert C. Korn","title":"Senior Vice President of Sales & Business Development"},{"age":null,"name":"Dr. Paul S. Larson FAANS, M.D.","title":"Chief Medical Officer"},{"age":null,"name":"Ms. Mary  McNamara-Cullinane RAC","title":"Senior Vice President of Regulatory Affairs"}],"industry":"Medical Devices","irWebsite":"","website":"https://www.clearpointneuro.com","phone":"888 287 9109"}}